There is a lot that we learned from BOSTON, and there’s a lot that we’re still learning. There was a time where bortezomib was intravenous twice weekly. Now…it’s once weekly subcutaneous, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results